INTRODUCTION
Patients with schizophrenia have been consistently shown to have reduced whole brain and cortical gray matter volume relative to matched controls (Ellison-Wright et al., 2008; Haijma et al., 2013) . Moreover, longitudinal brain morphometric studies show there are progressive reductions in gray and white matter volume in schizophrenia Kahn and Sommer, 2015; van Haren et al., 2008) . Similarly people at ultra high risk for psychosis (UHR), have reduced cortical and gray matter volumes (Dazzan et al., 2012) , and demonstrate evidence for progressive loss during the transition to psychosis (Cannon et al., 2015; Pantelis et al., 2003; Sun et al., 2009; Ziermans et al., 2012) . In contrast, elevations in white matter volume have been observed in schizophrenia, although less consistently (Walterfang et al., 2008; Witthaus et al., 2008) . It is interesting to note that the change over time in cortical volume has been found to be related to change in symptoms and a transition from at risk symptoms to first episode psychosis (Borgwardt et al., 2007b) . Baseline volumes have also been shown to act as a predictive marker for transition (Borgwardt et al., 2007a) .
Though the exact pathophysiology of the brain morphometric changes in schizophrenia is not clear, immune dysregulation has been suggested as an underlying mechanism (Bergink et al., 2014; Fillman et al., 2016; Kirkpatrick and Miller, 2013; Laskaris et al., 2016) . Supporting this, experimental animal studies of maternal immune activation show altered fetal brain development and behavioural and brain histopathological changes in offspring (Smith et al., 2007) . Elevated levels of pro-inflammatory cytokines have been associated with the reductions in gray matter volume in patients with schizophrenia (Meisenzahl EM, 2001) , and loss of gray matter in frontal cortex was associated with greater levels of pro-inflammatory cytokines in people at risk of psychosis who transitioned to psychosis (Cannon et al., 2015) . Microglia, the brain's resident immune cells, have a major role in synaptic pruning and phagocytosis within the central nervous system (Kreutzberg, 1996; Paolicelli et al., 2011) . They are both activated by pro-inflammatory cytokines and release them (Hanisch, 2002; Kreutzberg, 1996) . A recent rodent model based on immune loci identified in the largest genome-wide association study in schizophrenia to date showed that these genetic alterations lead to altered microglial pruning of synapses (Sekar et al., 2016) . Moreover, post mortem studies show elevated markers of inflammation (Fillman et al., 2013; Foster et al., 2006; van Kesteren et al., 2017; Volk et al., 2015) and elevated microglial cell density (with a hypertrophic morphology) in the brains of schizophrenia patients compared with healthy controls (Bayer et al., 1999) , particularly in the frontal and temporal lobes (Radewicz, 2000; van Kesteren et al., 2017) . A recent systematic review and meta-analysis of post mortem brain studies in schizophrenia found significant increase in the density of microglia in patients compared to healthy controls (van Kesteren et al., 2017) but another review did not find any consistent difference in microglia markers in schizophrenia (Trépanier et al., 2016) . Microglial activation might thus disrupt synaptic pruning to result in the gray matter volume loss seen in schizophrenia (Laskaris et al., 2016) . Supporting this, a recent post-mortem study has shown that greater inflammatory brain markers are associated with smaller brain volumes in schizophrenia (Zhang et al., 2016) .
Microglia express the 18kDa translocator specific protein (TSPO), a mitochondrial membrane protein, when they become activated, and can be indexed by PET tracers such as [
11 C]PBR28 that selectively bind to it (Brown et al., 2007; Owen et al., 2014; Owen et al., 2011) . Thus [ 11 C]PBR28 is an in vivo biomarker of microglial activation (Abourbeh et al., 2012; Dickens et al., 2014; Karlstetter et al., 2014; Lartey et al., 2014; Mattner et al., 2013; Rupprecht et al., 2010) . We have recently reported increased [ 11 C]PBR28 distribution volume ratio (DVR) in cortical gray matter in medicated patients with schizophrenia as well as UHR subjects when compared to healthy controls (Bloomfield et al., 2016b) using positron emission tomography (PET) imaging. This finding is consistent with some (Doorduin et al., 2009b; van Berckel et al., 2008) , but not all PET studies, which either have reported no change (Collste et al., 2017; Coughlin et al., 2016; Hafizi et al., 2017; Holmes et al., 2016; Kenk et al., 2015; van der Doef et al., 2016) or a decrease in volume of distribution (V T ) (Collste et al., 2017) in patients with psychosis or schizophrenia compared to healthy controls, suggesting there may be clinical or methodological differences between studies (Turkheimer et al., 2015b) . 
METHODS

Subjects
Fourteen subjects meeting UHR criteria, as assessed on the comprehensive assessment of the at risk mental state (CAARMS) (Yung et al., 2005) , were recruited from a London mental health clinic (Mean age ± SD: 24.3 ± 5.40; (M:F=7:7)).
Fourteen subjects with schizophrenia (Mean age ± SD: 47.0 ± 9.31; (M:F=12:2))
were recruited from London mental health centres (South London and Maudsley NHS Foundation Trust). A pool of 22 healthy control subjects recruited through newspaper and poster adverts were used to provide two groups (n=14 and n=14) of age and genotype matched subjects for the two experimental cohorts ( Table 1 ). The patients and controls were from the same study that was recently published (Bloomfield et al., 2016b) . The study was approved by the local research ethics committee and was conducted in accordance with the Declaration of Helsinki.
After complete description of the study to the subjects, written informed consent was obtained.
All subjects met the following inclusion criteria:
1. Aged 18+;
2. No significant physical or psychiatric health contraindications on assessment and medical examination by a trained physician.
Subjects were then screened based on the following exclusion criteria;
1. Exposure to any somatic medications, including anti-inflammatory medications, in the last 1 month.
History of substance abuse/dependence as determined by the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders
IV (DSM-IV) (SCID) (Spitzer et al., 1992) .
3. Benzodiazepine use, whether prescribed or not (Rao and Butterworth, 1997) . One subject was excluded due to a positive urine drug screening result for benzodiazepines on the scan day.
4. History of head injury resulting in unconsciousness, or any physical medical condition associated with inflammation.
5. At the time of screening, subjects were tested for TSPO genotype and subjects with a low affinity genotype were excluded as the PET radiotracer shows negligible specific binding (Owen et al., 2011) .
6. In UHR and control subjects: antipsychotic medication exposure.
7. Significant prior exposure to radiation 8. Pregnancy or breast feeding.
Healthy control subjects with a personal history of a psychiatric disorder or a first degree relative with schizophrenia or a psychotic illness were excluded.
PET Imaging
All subjects then received a bolus injection of [ 11 C]PBR28 (mean Mbq activity ±SD:
325.31 ± 27.03) followed by a 90-minute emission scan using a Siemens Biograph™
TruePoint™ PET-CT scanner (Siemens Medical Systems, Germany). A computer tomography (CT) scan was also acquired for attenuation and scatter correction.
Images were reconstructed using filtered back projection and binned into 26 frames of increasing time length (durations: 8 x 15 s, 3 x 1 min, 5 x 2 min, 5 x 5 min, 5 x 10 min). During the PET acquisition, arterial blood data were sampled via the radial artery using a combined automatic-manual approach. A continuous (one sample per second) sampling system (ABSS Allogg, Mariefred, Sweden) measured whole blood activity for the first 15 minutes of each scan. Discrete blood samples manually withdrawn at 5, 10, 15, 20, 25, 30, 40, 50, 60, 70, 80 , 90 minutes, were centrifuged to determine the plasma over blood activity ratio and filtered using HPLC to calculate the plasma fraction of authentic tracer free of metabolites (Tonietto et al., 2015; Tonietto et al., 2016) . For further details please refer to original study and its supplementary material (Bloomfield et al., 2016b) .
MRI imaging
Each subject underwent a MRI brain scan acquired with a 3T magnetic resonance imaging (MRI) scanner (Trio, Siemens Medical Systems, Germany). T1-weighted images were acquired with a 32-channel head coil (except for one subject where a 12-channel coil was used due to operator error) on a Siemens Tim Trio 
Image analysis MRI Cortical volume measures
Cortical reconstruction and volumetric segmentation on T1 weighted images were performed with the Freesurfer version 5.3 (http://surfer.nmr.mgh.harvard.edu) (Dale et al., 1999) . The procedure involved intensity normalization, automated topology corrections and automatic segmentations of cortical and subcortical regions. The PET, but not MR, data for these subjects have been reported in full (Bloomfield et al., 2016b (Dale et al., 1999) . The volumes of the cortical regions were used as input features to the regression model (see below). Widespread gray matter reductions are consistently reported in schizophrenia in total cortical gray matter, frontal cortex and temporal cortex and therefore these brain areas were selected as regions of interests (ROIs) Haijma et al., 2013; Honea et al., 2005) . In addition, we found increased [ 11 C]PBR28 relative binding in total cortical gray matter, frontal cortex and temporal cortex in patients with schizophrenia and individuals at risk of psychosis (Bloomfield et al., 2016b) . The frontal cortex included bilateral caudal middle frontal cortex, lateral orbitofrontal cortex, medial orbitofrontal cortex, pars opercularis, pars orbitalis, pars triangularis, rostral middle frontal cortex, superior frontal cortex, and frontal pole; the temporal cortex included bilateral banks of superior temporal sulcus, entorhinal cortex, fusiform cortex, inferior temporal cortex, middle temporal cortex, parahippocampal cortex, superior temporal cortex, temporal pole, and transverse temporal cortex.
PET imaging
All PET images were corrected for head movement using non-attenuation corrected images, as they include greater scalp signal, which improves re-alignment compared to attenuation-corrected images (Montgomery et al., 2006 were temporal and frontal lobe gray matter regions from the atlas (Radewicz, 2000) .
Quantification of [ 11 C]PBR28 tissue distribution was performed using the two tissue compartmental model accounting for endothelial vascular TSPO binding (2TCM-1K) (Rizzo et al., 2014; Veronese et al., 2017) , as this has been shown to have improved performance compared with the two tissue compartmental model not accounting for endothelial binding (2TCM) (Rizzo et al., 2014) . To account for variability of intersubject blood binding, typical of TSPO targeting tracers (Albrecht et al., 2016; Lockhart et al., 2003; Turkheimer et al., 2015b) , regional distribution volume estimates were normalized for whole brain activity in agreement with previous studies Zürcher et al., 2015) .
Our primary outcome measure therefore was the adjusted distribution volume ratio (DVR) calculated using an multiple analysis of covariance (MANCOVA) covarying for confounding factors that affect TSPO tracer binding (Turkheimer et al., 2015b) .
This approach produces estimated marginal means, in which the ROIs of interest are the dependent variables and genotype, age and whole brain signal are used as
covariates. There are data to suggest that cortical microglial activation, hence TSPO binding, is elevated with aging (Schuitemaker et al., 2012b) , which is also evident in our data (see (Bloomfield et al., 2016b) , Supplemental Table 2 ). TSPO genotype was included as a co-variate in correlation analysis as there is evidence that a single nucleotide polymorphism affecting the TSPO gene significantly affects binding of the tracer (Owen et al., 2011) . For this reason, we performed correlation analysis using age, genotype and whole brain signal as covariates. We also performed analysis using volume of distribution (V T ) as secondary outcome measure. Volume of distribution (V T ) is defined as the ratio of the radioligand concentration in target region to that in plasma at equilibrium .
Statistical analysis
Data, other than for gender and genotype, were shown to have a normal distribution following a Shapiro-Wilk test (Shapiro, 1965) . Hence parametric tests were implemented for all but gender and affinity analyses, where a Mann-Whitney U test was used. Demographic data and tracer activity data were analysed using independent-samples t-tests.
Within each cohort, multiple analysis of covariance (MANCOVA) was used to determine whether there was an effect of the group on [ 11 C]PBR28 adjusted DVR in the total cortical gray matter, frontal lobe, and temporal lobe, as well as on the total cortical gray matter volume and regional volumes within frontal and temporal lobes.
These regions were chosen as regions of interest based on previous microglial activation studies (Doorduin et al., 2009a; van Berckel et al., 2008) . For all statistical comparisons alpha was set at a 0.05 threshold (two-tailed) for significance. The results were reported in our recently published study (Bloomfield et al., 2016b) and presented in the supplementary table 1.
For cortical volume analysis, within each cohort, the volume of each cortical region was compared between the two groups with the t-test. A false discovery rate (FDR) at 0.05 was used to control the false positives across the multiple comparisons among the brain regions (Benjamini and Hochberg, 1995; Nichols and Hayasaka, 2003) .
The main objective was to investigate the relationship between cortical microglial activation and the cortical gray matter volume decreases in patients. We therefore investigated the relationship between the differences in the volume of cortical regions and microglial activation in cortical gray matter (as indexed by [ 11 C]PBR28 DVR). We performed a regression analysis of the total cortical gray matter [ 11 C]PBR28 DVR value (dependent variable) against all the regional cortical gray matter volumes (independent variables) as described above. As the number of investigated regions was larger than the number of observations, we implemented a regulation of the parameters with the elastic net regularized general linear models (Zou and Hastie) . Elastic net is a statistical regularization and variable selection method that prevents overfitting of the regression (Zou and Hastie). Because the parameter optimization is dependent on an internal cross-validation procedure, the performance of the regression may vary depending on sample stratification. To control the variability 'r', we performed 1000 iterations of the regression and used the mean correlative coefficients for the final regression model, and report the distribution of r and -logp values of the 1000 iterations (Carroll et al., 2009 ). The r values were between 0.7 and 1 and the -logp values were well beyond 2, indicating good fitting at a significance level of 0.01 or lower across all the iterations. The resulting regressed DVR and the DVR measured in our study was evaluated with
Pearson's correlation analysis to investigate the accuracy of the regression. To further investigate the localized relationship between the DVR and cortical region volumes, we also performed exploratory analyses using the same regression analysis within the DVR and regional volumes of the frontal cortex, as well as the DVR and regional volumes of the temporal cortex. The primary region of interest was total cortical gray matter. For the total cortical gray matter DVR, regression included all 68 regions of the cortex (i.e to identify which of the 68 cortical regional variables were most associated with cortical gray matter DVR). In the exploratory analyses, for the frontal and temporal lobe DVR, we included 18 regions within frontal and temporal cortex as secondary regions of interests, respectively. The regression analysis was performed with MATLAB (version R2013a,
The Mathworks Inc., Natick, Massachusetts) with glmnet package (Qian et al., 2013) .
RESULTS
Cortical Gray Matter Volume Analysis (SCZ vs Controls)
The total cortical gray matter volume was significantly lower in SCZ than the healthy controls (p=0.02) ( Table 1) . Temporal cortical gray matter volume was also lower in Scz than controls but not frontal cortical gray matter volume (Table 1) . Whole brain analysis with false discovery rate set at 0.05, revealed significantly lower gray matter volumes in schizophrenia patients compared to healthy control subjects in the following three regions; left cuneus, right superior parietal cortex and right transverse temporal cortex (Table 1) .
Cortical Gray Matter Volume Analysis (UHR vs Controls)
The total cortical, frontal or temporal gray matter volume was not different between the UHR and the controls (Table 1) . No significant volume difference was observed in the whole brain analysis at FDR 0.05.
Table 1 (to be inserted)
Relationship between [ 11 C]PBR28 DVR and brain volume in the SCZ
Total cortical gray matter [ 11 C]PBR28 DVR and brain volume
In the schizophrenia patients the volumes of cortical regions were significantly related to total cortical gray matter 
Figure 1 (to be inserted)
Regional cortical gray matter [ 11 C]PBR28 DVR and brain volume
In this exploratory analyses, we also found that in the schizophrenia patients the gray matter DVR in the temporal cortex was significantly related to the volumes of left temporal pole, right superior temporal cortex, left and right entorhinal cortex, and right transverse temporal cortex (r=0.94; p<0.0001; Figure 4 ). The region with the highest absolute regression coefficient was the left temporal pole, which showed a negative correlation with the temporal cortical GM DVR (r=-0.72; p=0.005; Figure 5 ).
The distributions of the r and p values for the 1000 iterations are shown in Figure 6 .
In contrast, there was no significant fit between the DVR values of the frontal lobe with the frontal volumes. Finally, direct regional correlations between [ 11 C]PBR28 DVR and MRI volume for cortical GM, frontal lobe, and temporal lobe in both schizophrenia patients and UHR subjects matched to their respective control groups were not significant (p>0.05).
Relationship between [ 11 C]PBR28 V T and brain volume
In the schizophrenia patients, the regression model found a significant fit between the total cortical gray matter V T with the cortical region volumes (r=0.98; p<0.001) and temporal lobe (r=-0.88; p<0.001). However, none of the regions used in the regression correlated with the V T of the total cortical or temporal gray matter, which may indicate additive effect that otherwise were not predictive for V T individually.
There was no gray matter volume ROI that was statistically significantly correlated with V T ( Supplement Fig 1) , though there was a trend towards a negative correlation between V T and gray matter volume in the temporal lobe (left transverse temporal volume r=-0.51; p=0.07; Supplement Fig 2) . There was no significant fit between the frontal region V T values with the frontal volumes.
In the UHR subjects, the regression model found a significant fit between the total cortical gray matter V T with the cortical region volumes (r=0.90; p<0.001), temporal lobe (r=0.68; p<0.001) and frontal lobe (r=0.80; p<0.001). The region with the highest absolute correlation coefficient was the right pars orbitalis cortex, and its volume was positively correlated with the total cortical gray matter V T (r=0.76; p=0.002; Supplement Fig 3) . For temporal gray matter V T , the highest absolute correlation coefficient was the left transverse temporal area (r=0.61; p=0.02; Supplement Fig 4) and for frontal lobe was right pars orbitalis cortex (r=0.71; p=0.004; Supplement Fig 5) .
DISCUSSION
In this experiment, we investigated the relationship between cortical volumes and TSPO signal from [ 11 C]PBR28 PET scans in patients with schizophrenia, UHR subjects and respective matched control groups. We demonstrated that patients with schizophrenia exhibit a negative relationship between total cortical gray matter
[11C]PBR-28 DVR and cortical gray matter volumes, and this was also seen for temporal cortex DVR and temporal cortical volumes. The lack of relationship in the healthy control subjects may suggest that relationship between total cortical gray matter [11C]PBR-28 DVR and cortical gray matter volumes is disorder specific. It is also possible lack of relationship in the healthy control subjects is due to the limited
[11C]-PBR-28 DVR range in this cohort. In the UHR group, although the regression model fitted the DVR values of total cortical and temporal gray matter with the respective cortical region volumes, no individual regions showed any significant correlation.
To our knowledge this study is the first to investigate the relationship between microglia and cortical volumes in schizophrenia and UHR cohorts using multimodal imaging. Our findings are consistent with the hypothesis that microglial activation leads to GM volume reduction, but, as they are associations, a direct causal relationship cannot be inferred. Although the regression model indicated there is a relationship between DVR and gray matter volumes in the UHR group, there was no single region that showed a correlation between [ 11 C]PBR28 DVR and cortical volumes. This difference with the schizophrenia results may reflect illness progression as UHR subjects are earlier in the development of disorder and many UHR subjects do not go on to develop schizophrenia. It would be interesting to follow up the UHR cohorts to examine the brain GM volume change and [ 11 C]PBR28 signal during the course of the prodromal period to determine if there is a change with illness progression.
A similar significant inverse correlation between [ 11 C]PBR28 binding and gray matter volume is also observed in patients with Alzheimer's disease and mild cognitive impairment (Kreisl et al., 2013) . Further experimental studies are required to determine the biological significance of elevated microglial activity in the context of brain volume changes in schizophrenia (Laskaris et al., 2016 (Bloomfield et al., 2016b) . We found >30%
level of V T variability likely due in part to a small free fraction (fp) and DVR normalization reduced intersubject variability and thus possibly improved the signal to noise in our data (Bloomfield et al., 2016b) . Therefore, it is not surprising that we did not find any significant correlation between [ 11 C]PBR28 V T and cortical gray matter or regional (temporal or frontal) volume in patients with schizophrenia. These differences may be accounted for by methodological issues (see discussion below).
Notwithstanding this, the direction of both the V T and DVR correlations is consistent with the direction of alteration seen in schizophrenia for the respective measure in temporal lobe (a trend level negative correlation between [ 11 C]PBR28 V T and in temporal lobe). Finally, we observed a direct correlation between [ 11 C]PBR28 V T and cortical volumes in UHR subjects. This is not what we expected and we think that this is likely due to noise in the data due to the fact that we did not find any significant differences in the gray matter volume or [ 11 C]PBR28 V T between UHR subjects and healthy controls.
We used distribution volume ratio (DVR) as the main outcome measure and other groups used distribution volume (V T ) or binding potential (BP). There is currently no universal consensus on the optimum analytical approaches for estimation of microglial activation using TSPO tracers (Bloomfield et al., 2016a; Narendran and Frankle, 2016; Turkheimer et al., 2015b) . DVR as an outcome measure has been validated in animals, where inflammatory stimuli increase DVRs and microglial markers (Converse et al., 2011; Imaizumi et al., 2007) and also in other human studies using [ 11 C]PBR28 (Dimber et al., 2016; Lyoo et al., 2015) and [ 11 C]-(R)-PK11195 (Rissanen et al., 2014) . V T is generally accepted to be the preferred outcome measure in the absence of a clear reference region. However, this is problematic for TSPO tracers for a number of reasons. Accurate V T estimation relies on two assumptions; first, the availability of reliable plasma input function measurement and second, that there are no systematic group differences in free parent radiotracer plasma levels. In our cohort of Schizophrenia patients, we observed a very low free parent radiotracer plasma levels (~2%) and the parent plasma levels were significantly different across group (patients vs controls) (Bloomfield et al., 2016a) . Therefore accurate V T determination is not possible and potentially unreliable (Turkheimer et al., 2015a) . Another issue is the confounding effect of plasma protein bound to plasma tracer. Binding of TSPO tracers to plasma proteins has been reported (Lockhart et al., 2003) . which indicates this could confound V T estimation as studies show patients with schizophrenia show elevated acute phase protein in peripheral blood (Bloomfield et al., 2016a) . Thus, in our study, we think DVR is less likely to be affected by differences in plasma proteins compared to V T . However, it should be noted that interpretation of DVR increases is not straightforward as there is no brain region devoid of TSPO, and further work is warranted to confirm the relationships observed. This issue is discussed in detail elsewhere (Bloomfield et al., 2016a; Turkheimer et al., 2015b) .
Limitations
Except one patient with schizophrenia, all were taking antipsychotic medications (Supplementary Table 2 ) which may be a potential confounder moderating the relationship between microglial activity and brain GM volume. Antipsychotic medications are associated with brain volume reductions in schizophrenia ) but volume change is related to illness progression after adjusting for antipsychotic effects (Van Haren et al., 2013) . Some preclinical evidence suggests that antipsychotic medication may possess anti-inflammatory properties (Mondelli and Howes, 2014) by reducing microglial activity (Bian et al., 2008; Kato et al., 2008; Zhu F, 2014) , although at higher doses they may increase microglial activity (Cotel et al., 2015) . A recent study using [ 11 C]-(R)-PK11195 to index TSPO availability, found significantly elevated [ 11 C]-(R)-PK11195 in medicated patients (N=8) (taking monthly intramuscular injections of either Risperidone or Paliperidone) compared with healthy controls in prefrontal, anterior cingulate and parietal cortical regions (Holmes et al., 2016) . However there were no significant differences in [ 11 C]-(R)-PK11195 availability in antipsychotic-free patients (Holmes et al., 2016 Due to modest sample size in this study, the results have to be interpreted with caution. To reduce the possibility that our results were acquired by chance, we also 
Future directions
The causal relationship between neuroinflammation and brain volume changes will likely require longitudinal clinical studies that specifically look into whether TSPO changes predict the onset or worsening of brain volume reduction in individuals prior to the onset of psychosis and are antipsychotic medication naïve.
Conclusions
In schizophrenia cortical volume reduction is associated with elevated microglial activation using a multimodal neuroimaging approach. This relationship was also observed at a marginal level in UHR subjects suggesting the relationship may become stronger with the development of the disorder. (a) (b)
TABLES
Controls (CTRL); Schizophrenia (SCZ); gray matter (GM); Distribution volume ratio (DVR).
Temporal GM DVR (a) (b)
